Eli Lilly and Comp. (LLY) stock forecast for 2022. Forecast tables and graphs.

Eli Lilly and Comp. (LLY) stock forecast for 2022

The forecast has been updated: September 16, 2021 8:38


Eli Lilly and Comp. stock price online today

Analyst Target Price

262.24

Dividend Date

10.09.2021

Ex Dividend Date

12.08.2021

Last Split Factor

2:1

Last Split Date

16.10.1997

Should you buy or sell Eli Lilly and Comp. stock stock today? What is the projected target price level for 2022? How much will it cost in 2022? Eli Lilly and Comp. stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2022.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $262.24 target price for Eli Lilly and Comp. stock stock.

Today 200 Day Moving Average is the support level (218.52 $).

50 Day Moving Average is the resistance level (257.87 $).




LLY Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 275.92 263.73 299.60 11.97 %
Feb 268.03 247.47 289.29 14.45 %
Mar 268.38 251.28 279.89 10.22 %
Apr 301.53 273.69 316.03 13.40 %
May 302.70 276.73 329.46 16.01 %
Jun 320.80 301.62 332.06 9.17 %
Jul 291.61 266.59 313.98 15.09 %
Aug 302.22 290.44 332.48 12.64 %
Sep 299.47 281.18 329.45 14.65 %
Oct 331.40 315.03 356.39 11.61 %
Nov 371.89 338.54 387.37 12.61 %
Dec 413.47 401.11 455.40 11.92 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Eli Lilly and Comp. stock.


Eli Lilly and Comp. overview

Eli Lilly and Comp. Address

LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, US

Market Capitalization

226 097 480 000 $

EBITDA

9 068 400 000

PE Ratio

35.54

PEG Ratio

1.694

Dividend Per Share

3.18

Dividend Yield

0.0136

EPS

6.65

Quarterly Earnings Growth YOY

-0.013

Quarterly Revenue Growth YOY

0.226

Trailing PE

35.54

Forward PE

27.32

EV To Revenue

9.07

EV To EBITDA

27.62

52 Week High

275.87

52 Week Low

127.05

50 Day Moving Average

257.87

200 Day Moving Average

218.52

Shares Outstanding

956581000

Shares Float

854688000

Shares Short Prior Month

6770700

Short Ratio

2.49

Percent Insiders

0.153

Percent Institutions

84.86

Eli Lilly and Comp. stock forecast for this year


Eli Lilly and Comp. stock forecast for Jan 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 275.92. Positive monthly dynamics of the instrument is expected with 11.973% volatility is expected.

Pessimistic forecast: 263.73

Optimistic: 299.60


Eli Lilly and Comp. stock forecast for Feb 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 268.03. Negative monthly dynamics of the instrument is expected with 14.454% volatility is expected.

Pessimistic forecast: 247.47

Optimistic: 289.29


Eli Lilly and Comp. stock forecast for Mar 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 268.38. Positive monthly dynamics of the instrument is expected with 10.221% volatility is expected.

Pessimistic forecast: 251.28

Optimistic: 279.89


Eli Lilly and Comp. stock forecast for Apr 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 301.53. Positive monthly dynamics of the instrument is expected with 13.396% volatility is expected.

Pessimistic forecast: 273.69

Optimistic: 316.03


Eli Lilly and Comp. stock forecast for May 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 302.70. Positive monthly dynamics of the instrument is expected with 16.005% volatility is expected.

Pessimistic forecast: 276.73

Optimistic: 329.46


Eli Lilly and Comp. stock forecast for Jun 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 320.80. Positive monthly dynamics of the instrument is expected with 9.168% volatility is expected.

Pessimistic forecast: 301.62

Optimistic: 332.06


Eli Lilly and Comp. stock forecast for Jul 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 291.61. Negative monthly dynamics of the instrument is expected with 15.092% volatility is expected.

Pessimistic forecast: 266.59

Optimistic: 313.98


Eli Lilly and Comp. stock forecast for Aug 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 302.22. Positive monthly dynamics of the instrument is expected with 12.644% volatility is expected.

Pessimistic forecast: 290.44

Optimistic: 332.48


Eli Lilly and Comp. stock forecast for Sep 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 299.47. Negative monthly dynamics of the instrument is expected with 14.653% volatility is expected.

Pessimistic forecast: 281.18

Optimistic: 329.45


Eli Lilly and Comp. stock forecast for Oct 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 331.40. Positive monthly dynamics of the instrument is expected with 11.605% volatility is expected.

Pessimistic forecast: 315.03

Optimistic: 356.39


Eli Lilly and Comp. stock forecast for Nov 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 371.89. Positive monthly dynamics of the instrument is expected with 12.606% volatility is expected.

Pessimistic forecast: 338.54

Optimistic: 387.37


Eli Lilly and Comp. stock forecast for Dec 2022.
Estimated Average Forecasted Eli Lilly and Comp. Price: 413.47. Positive monthly dynamics of the instrument is expected with 11.921% volatility is expected.

Pessimistic forecast: 401.11

Optimistic: 455.40



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 127.44 (16.09.2021) -0.04 %
AbbVie Inc.
ABBV 108.08 (16.09.2021) 0.29 %
Aeterna Zentaris Inc.
AEZS 0.6143 (16.09.2021) -0.73 %
Allakos Inc.
ALLK 105.77 (16.09.2021) -2.27 %
Allogene Therapeutics, Inc.
ALLO 24.51 (16.09.2021) -1.96 %
Amgen Inc.
AMGN 217.36 (16.09.2021) -0.35 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 15.87 (16.09.2021) -0.19 %
Aurora Cannabis Inc.
ACB 6.62 (16.09.2021) -0.90 %
Becton Dickinson and Company
BDX 262.67 (16.09.2021) 0.38 %
Biogen Inc.
BIIB 299.69 (16.09.2021) 0.16 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 136.93 (16.09.2021) 0.69 %
BioNTech SE
BNTX 372.65 (16.09.2021) 4.90 %
bluebird bio, Inc.
BLUE 17.68 (16.09.2021) -0.67 %
Boston Scientific Corp.
BSX 44.9 (16.09.2021) -0.24 %
Bristol-Myers Squibb Company
BMY 61.23 (16.09.2021) -1.24 %
Canopy Growth Corp.
CGC 14.83 (16.09.2021) 0.27 %
Castle Biosciences, Inc.
CSTL 76.21 (16.09.2021) 1.99 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 8.14 (16.09.2021) -0.37 %
Eli Lilly and Company
LLY 231.04 (16.09.2021) -1.15 %
Emergent BioSolutions Inc.
EBS 57.47 (16.09.2021) 0.56 %
Exelixis, Inc.
EXEL 20.54 (16.09.2021) 0.34 %
G1 Therapeutics, Inc.
GTHX 14.27 (16.09.2021) 2.37 %
Gilead Sciences, Inc.
GILD 71.33 (16.09.2021) -0.60 %
GlaxoSmithKline plc
GSK 39.11 (16.09.2021) -0.28 %
GoodRx Holdings, Inc.
GDRX 45.93 (16.09.2021) 3.70 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 75.04 (16.09.2021) 2.18 %
Inovio Pharmaceuticals, Inc.
INO 7.75 (16.09.2021) 2.38 %
Johnson & Johnson
JNJ 165.22 (16.09.2021) -0.12 %
Medtronic plc.
MDT 130.92 (16.09.2021) -0.55 %
Merck & Co., Inc.
MRK 71.97 (16.09.2021) -1.15 %
Moderna, Inc.
MRNA 440.65 (16.09.2021) 1.42 %
Novartis AG
NVS 84.38 (16.09.2021) -0.82 %
Novavax, Inc.
NVAX 237.27 (16.09.2021) 2.14 %
ObsEva SA
OBSV 3.08 (16.09.2021) 0.65 %
OrganiGram Holdings Inc.
OGI 2.4 (16.09.2021) -0.83 %
Pfizer Inc.
PFE 44.47 (16.09.2021) -0.67 %
Regeneron Pharmaceuticals, Inc.
REGN 653.18 (16.09.2021) 0.18 %
Sanofi
SNY 48.19 (16.09.2021) 0.37 %
Schrodinger, Inc.
SDGR 61.15 (16.09.2021) 0.30 %
Senseonics Holdings, Inc.
SENS 3.82 (16.09.2021) -1.29 %
Sorrento Therapeutics, Inc.
SRNE 8.08 (16.09.2021) 1.76 %
Stryker Corp.
SYK 276.11 (16.09.2021) -0.36 %
Sundial Growers Inc.
SNDL 0.7193 (16.09.2021) -1.44 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.95 (16.09.2021) -0.22 %
Thermo Fisher Scientific Inc.
TMO 560.44 (16.09.2021) -0.45 %
Tilray, Inc.
TLRY 12.01 (16.09.2021) -0.17 %
UnitedHealth Group, Inc.
UNH 416.84 (16.09.2021) -0.16 %
Veeva Systems Inc.
VEEV 305 (16.09.2021) 1.75 %
Zomedica Corp.
ZOM 0.5393 (16.09.2021) 1.56 %
Zynerba Pharmaceuticals, Inc.
ZYNE 4.32 (16.09.2021) -0.69 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.